TISSUE INHIBITOR OF MATRIX METALLOPROTEINASES TYPE-1 (TIMP-1) AS A POSTOPERATIVE MARKER FOR MINIMAL RESIDUAL DISEASE OR RECURRENT DISEASE IN PATIENTS WITH A PRIOR HISTORY OF CANCER
Details for Australian Patent Application No. 2003226925 (hide)
International Classifications
Event Publications
7 August 2003 Complete Application Filed
Priority application(s): PA 2002 00510 08.04.02 DK
4 December 2003 Application Open to Public Inspection
Published as AU-A-2003226925
23 December 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
18 August 2005 Corrigenda
Applications OPI - Name Index Under the name RIGSHOSPITALET, Application No. 2003226925, under INID (71) correct the name to read RIGSHOSPITALET; HVIDOVRE HOSPITAL
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2003226926-Novel methoxybenzamide compounds for use in MCH receptor related disorders
2003226924-A CONDENSATION VESSEL AND METHOD OF CONDENSATION OF A REFRIGERANT
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
![](/images/main/3dbox_small.png)
- Editable Word format reports
- For IP Professionals
- Multiuser